FROM 01 Jun, prescribing of oral ivermectin for 'off-label' uses will no longer be limited to specialists such as dermatologists, gastroenterologists and infectious diseases specialists, the TGA has stated.
In its final decision published yesterday, the TGA has removed the restriction through its scheduling in the Poisons Standard because there is sufficient evidence that the safety risks to individuals and public health is low when prescribed by a general practitioner in the current health climate.
However, the TGA asserted that it does not endorse off-label prescribing of ivermectin for the treatment of COVID-19.
The above article was sent to subscribers in Pharmacy Daily's issue from 04 May 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 04 May 23
